Halozyme Therapeutics (HALO) PT Raised to $26 at BMO Capital

Go back to Halozyme Therapeutics (HALO) PT Raised to $26 at BMO Capital
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.83 -0.48 (0.44%)
Previous Close $108.31    52 Week High $18.39 
Open $107.67    52 Week Low $6.96 
Day High $108.79    P/E N/A 
Day Low $106.83    EPS $-0.58 
Volume 366,188